MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3.
Saved in:
| Title: | MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3. |
|---|---|
| Authors: | Yamamura A; Department of Physiology, Aichi Medical University, Nagakute, Japan., Nayeem MJ; Department of Physiology, Aichi Medical University, Nagakute, Japan., Muramatsu H; Department of Urology, Aichi Medical University, Nagakute, Japan., Nakamura K; Department of Urology, Aichi Medical University, Nagakute, Japan., Sato M; Department of Physiology, Aichi Medical University, Nagakute, Japan. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2021 Apr 20; Vol. 12, pp. 667474. Date of Electronic Publication: 2021 Apr 20 (Print Publication: 2021). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
